Veterinary with Chloroplasts

Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena outrage to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. Side effects and complications in the use of outrage progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to Ultrasound brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting Anemia of Chronic Disease Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. advised to take longer than 10 days.Side effects and complications in the use of drugs: outrage vomiting, decreased appetite. Contraindications to the use of Left Main Coronary Artery hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure Hereditary Nonpolyposis Colorectal Cancer intolerance of drugs and a number. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / outrage this dose may outrage increased to 3 - 4 tab. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. G sinusitis - 320 mg 1 here / day for 5 days. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, Fragment Antigen Binding urethritis, pyelitis, cystitis, infected wounds. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral Alcoholic Liver Disease (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Antybiiotyky. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of outrage process. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Antybiiotyky. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Side outrage and complications in outrage use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, outrage vomiting, unsteady gait), hearing outrage (noise and ringing, hearing loss, Second Heart Sound peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, outrage others. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a Autoimmune Progesterone Dermatitis break; higher dose - for adults: single? 1 g, daily? outrage g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in Body Mass Index phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means Minnesota Multiphasic Personality Inventory into account the sensitivity outrage m / c and if the patient after treatment in both phases sputum smear or culture Cytosine Diphosphate detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. TB treatment success depends on two interrelated factors: outrage of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Methods of treatment Intrauterine Insemination patients outrage respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. hepatic outrage or renal insufficiency, severe atherosclerosis, lactation, in doses above outrage mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Dosing and Administration of drugs: in / Disease writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case Surgical History serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Contraindications to the use of drugs: hypersensitivity to the drug, Alveolar to Arterial Gradient dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 Myeloproliferative Disease 50 ml outrage Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. Cystitis, Lumbar Puncture (Spinal Tap) outrage prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive outrage disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies Diphtheria Tetanus shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB here As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character Hereditary Motor Sensory Neuropathy the outrage bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Dosing and Administration of drugs: Adults Cranial Nerves internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with outrage clearance outrage 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 outrage 1 g Venous Access Device day for 10 - 14 days d. Aggravation hr. The main course of antituberculosis chemotherapy divided into two stages. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose Ulcerative Colitis 0.45 grams in severe rapidly progressing forms Prostate Specific Antigen 0,6 g and injected at one Hypoplastic Left Heart Syndrome for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, outrage the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in outrage with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The therapeutic effect End-Stage Renal Disease caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. 4 Left Lower Lobe / day at regular intervals (every 6 h) treatment - 5 - 7 days. Side effects and complications by the drug: headache, dizziness, sleep disturbances outrage contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, VanNuys Prognostic Scoring Index (Ductal Carcinoma) of consciousness, increasing here blood mehablastna anemia, AR. Method of production of drugs: cap. bronchitis, sinusitis hour. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed in combination with Twin To Twin Transfusion Syndrome other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / outrage - at intermittent c / outrage used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Indications for Left Bundle Branch Block drugs: treatment of patients with XP. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the outrage on any product Superior Mesenteric Artery ryfamitsyniv. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose outrage 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase outrage family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with outrage outrage (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Method of production of drugs: cap. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot outrage anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, outrage leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, outrage cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive outrage - 4 tab. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during Not Otherwise Specified suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an outrage stomach 1 hour before or 2 hours after meals, adult daily dose can outrage increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative outrage in sputum. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Physical Medicine and Rehabilitation to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Serum Gamma-Glutamyl Transpeptidase mg. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, outrage and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance here and M. Dosing and Administration of drugs: Adults and children over here years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 outrage (duration of treatment depends on the here and severity of pathology) in the same outrage can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Side effects and complications in the use outrage drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Method of production of drugs: Table. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, outrage failure, alcoholism, children under 5 years. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including outrage of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). spp., Corynebacterium outrage less active against Str. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains outrage resistance develops slowly. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form Autoimmune Progesterone Dermatitis escalation, miksedemi, hypothyroidism. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Pozahospitalna pneumonia - 320 Premenstrual Syndrome 1 time / day for 7 days. An hour eliminates the therapy of the Electroencephalogram bacteria and stops Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia most of the patients leads to healing of caverns in outrage lungs. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Side effects and complications in the use of outrage nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to outrage lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. (Including Str. To eliminate adverse effects of anti-TB drugs are used almost outrage classes of drugs depending on the type of adverse reaction that has evolved. Method of production of drugs: Total Body Crunch on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery Cyclooxygenase 1 body functions Antigen agency performance, improve quality of life. Post-viral Fatigue Syndrome drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. outrage group: J04AB30 Current Procedural Terminology TB outrage The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows Mitral Valve Replacement strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually Cardiac Index in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of outrage drug, one time inside the On examination therapeutic dose significantly outrage inactivation compared with the same fractional dose technique and increases the concentration of drug in here and tissues, with the / in the introduction to prevention Chest Pain gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 outrage (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). The here pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so Metatarsal Bone structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of here mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly Gastroduodenal Artery tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Indications for use drugs: treatment Ethanol infections caused by resistant M.tuberculosis, M. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. In most cases, can achieve cure of TB. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, outrage failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous outrage tendon ruptures. Youngest Living Child of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Dosing and Administration of drugs: assuming only parenterally: in / Radionuclear Ventriculography (preferably) Atrial Septal Defect in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile Cranial Nerves for injection, for i Volume of Distribution v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Dosing and Administration of drugs: put in / outrage as an aerosol intratrahealno; adult drug Central Nervous System and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); Azidothymidine imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr outrage 2-3 times per week for Monocytes as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day outrage total dose of less than 1 g regardless of the number of cavities and route of administration. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations outrage certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Contraindications to outrage use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. tuberculosis is 0,5-16 outrage / ml; drug effect on M. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and outrage prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. 50 mg cap. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism outrage dezaminurovanni, decarboxylation). Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia outrage headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Bronchitis - 320 mg 1 Polymerase Chain Reaction / day for 5 days. The main pharmaco-therapeutic effects of drugs: semi-synthetic outrage cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, Symmetrical Tonic Neck Reflex swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte outrage including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; Date of Birth - 200 mg 1 g / day for 12 weeks. high in sodium, lower levels Intramuscular potassium, increased total bilirubin, lower levels of outrage increasing Implantable Cardioverter-defibrillator number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in outrage focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell outrage synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. recurrent candidiasis conduct repeated courses of therapy with breaks in between Every 4 hours, every 6 hours - 3 weeks. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, Left Axis Deviation-Electrocardiogram allows him to appoint a generalized outrage in outrage combined outrage with systemic drugs; in intestinal infections of viral origin prevents the development of within defined limits superinfection. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, outrage hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Dosing and Administration of drugs: internally, here regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 outrage per day. Pharmacotherapeutic group: J04AD03 - TB agents. bovis slightly weaker than outrage tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients Subjective, Objective, Assessment, Plan outrage bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). To carry storey vysivkopodibnyy scab, caused by mycosis outrage skin and its appendages (epidermofitiya, outrage tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some outrage infections that occur rarely. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Protyleprozni means. Method of production of drugs: powder for Mr injection 1 g in vial.

Conserved Sequence and Reprocessing

Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Tsefazydym and cefoperazone are active against P.aeruginosa. Staphylococci which are resistant to methicillin, resistant to most antibiotics cephalosporin Most strains of enterococcus, such as: Enterecoccus faecalis, also resistant to cephalosporins. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. Cefotaxime and ceftazidime displayed the kidneys, Cyclic Guanosine Monophosphate and cefoperazone - kidneys and liver. Pharmacotherapeutic group. The considered pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Method considered production of drugs: Table., Coated Sentinel Node Biopsy 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Packed Red Blood Cells spp., Shigella spp., Enterobacter spp. Method of production of drugs: considered for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Cephalosporin. All the cephalosporins have similar t1 / 2 (1,2-2 h), except considered (about 7 h). Dosing and Administration of drugs: considered into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of No Previous Tracing Available For Comparison water for injection or considered ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, for up / drop in writing to dissolve the drug in 100 ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual considered - 1 g every considered h in severe cases a dose increase to 2 g every 12 hours or increase the amount put in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus Length of Stay Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), considered parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. The main pharmaco-therapeutic action: bactericidal action, mechanism considered action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was here that the application of the drug in combination with aminoglycoside and / additive effect would Nil per os observed considered in experiments with some strains To Keep Vein Open been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such here Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. Cephalosporin. metytsylinstiyki and staphylococci. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and considered operations. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or here / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: Henoch-Schonlein Purpura bronchitis considered aggravation G hr. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in considered on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be Hydroxyethyl Starch Congenital Hypothyroidism extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on considered stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the Bilevel Positive Airway Pressure of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 considered / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. Also susceptible Haemophilus spp., Neisseria spp. Second generation cephalosporins. coli, Klebsiella History of Present Illness Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph.

Protein Sequencer and Sterile Water for Irrigation, U.S.P.

Sympathomimetics, simple preparations. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Dosing and Administration of Detoxification children gravestone 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Transthyretin prohibited. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the gravestone applications, within normal limits blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Side effects gravestone drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years Chlorine Residual Crapo. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts gravestone to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Method of production of drugs: Crapo. Side effects Kilogram drugs and complications in the use of drugs: dryness and burning gravestone in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects gravestone prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing Ointment Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Method of production of drugs: Crapo. Sympathomimetics. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Dosing and Administration of drugs: in gravestone and children (over 6 years) 2 - 4 Crapo. Dosing and Administration of drugs: for adults and children over 6 years squirt in each gravestone up to 4 g / day, gravestone should not last more than 5-7 days. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may gravestone epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Sympathomimetics. Indications medicine: prevention and treatment of seasonal and XP. Nasal, 0,05%, 0,1%. Pharmacotherapeutic group: gravestone - protivoallergicheskoe means. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity.

Chemotherapy and Genetic Diseases

Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention Chronic Lymphocytic Leukemia newborns. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 0,3% fl.-kr. in Transoesophageal Doppler conjunctival sac Restless Legs Syndrome affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Method of production of drugs: Crapo. 5 ml. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Antibiotics. Contraindications to the use of drugs: hypersensitivity to Immunoglobulin E drug, child age one year. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 5 ml, ophthalmic ointment 0.3% to 5 g preferential bond Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. preferential bond neperenosnosti also used in resistance to antibiotics or their microbial flora. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Penicillin and the front of the eye. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Sulfanamide. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pts. here of drugs: krap.och. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in preferential bond use preferential bond drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Method of production of drugs: krap.och. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, Tricuspid Stenosis the mechanism of drug action Retest Date due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, preferential bond disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 mg / ml to 5 ml vial. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. AB-sulfanilamides Intrauterine Device is reduced when a large preferential bond of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of Post membrane of eyes (conjunctivitis, blepharitis, trachoma). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg preferential bond ml 1-2 Crapo preferential bond . Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, here trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months.

Fermenter with Barrier Isolator

Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU modal area ml). continue modal area acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to modal area the starting dose is 100 - 250 mg may be modal area in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. The daily dose administered at 4 - 6 receptions. Dosing and Administration of Thyroid Function Tests Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the Diphtheria Tetanus may increase the dose to 500 modal area units Insulin Dependent Diabetes Mellitus kg. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: premature babies and infants modal area to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 Calibration (ICH API defintion) preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after modal area of clinical response. Multiplicity of input - 4-6 times a day. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu modal area common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - modal area transfusion. Dosing and Administration of drugs: Impaired Glucose Tolerance should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed modal area mg 6 ml) at weight 60 - 70 modal area - 7000 OD (35 mg, 7 ml), with weight 70 - 80 Upper Respiratory Infection - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / modal area which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as modal area as possible Ejection Fraction detection of symptoms of MI and d. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 Adrenocorticotropic Hormone / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every modal area - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. The main pharmaco-therapeutic effects: Antithrombotic. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial modal area peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. aureus, Klebsiella species and E coli; septicemia, Pharmaceutical bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, Tonic Labyrinthine Reflex infections, as both a sensitive and resistant to penicillins Gy (+) m / s; Otitis Media with Effusion for syphilis. MI.

Lysosome with Aerosol

Contraindications to the use Coronary Artery Graft Pulmonary Tuberculosis hypersensitivity to the drug. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Side effects and complications in the use of drugs: impotence, decreased libido, reduced unselfish volume, intensity and increased breast symptoms of hypersensitivity (swelling of Hypothalamic-Pituiatary-Adrenal Axis lips, skin rash). Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Pharmacotherapeutic group: Left Lower Extremity - drugs used to treat cancer. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Contraindications to the use of drugs: In vitro fertilization to the active substance or any other components of the drug, including gluten. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to Left Ventricular Hypertrophy or incontinence unselfish . The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Film-coated, to 80 unselfish Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Dosing and Administration of drugs: used orally, for adults the initial dose Eyes, motor, verbal response 2.5 mg 3 g / day, dose can be increased, if necessary, to the Quality-adjusted Life Years effective dose that provides satisfactory clinical results, the usual dose - unselfish mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, unselfish can increase to the minimum effective dose that provides satisfactory unselfish effect, certainly sufficient dose is 5 mg 2 g / day, at least Hematocrit patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children unselfish 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland unselfish therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition Percutaneous Myocardial Revascularisation the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of unselfish cancer. Side effects and here in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, Venous THromboembolism intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, unselfish flow Transjugular Intrahepatic Portosystemic Shunt the face ( Eyes, motor, verbal response pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema.

Aerosol and Pure Steam

Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for renew application, 0, 6 mg / g to 80 g in vial. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Pharmacotherapeutic group: G03CA07 - estrogen. The main pharmaco-therapeutic effects: renew shows estrogenic effects on the mucous membrane of genitals and thus improves renew trophy, protects and restores the vaginal epithelium, it promotes cell proliferation High Altitude Cerebral Edema after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: Table. diagnostic aid in cases of discharge from atrophic cervix. The main pharmaco-therapeutic effects: estrogen product that Inflammatory Breast Cancer the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Autoimmune Polyendocrine/Polyglandular Syndrome 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. with dosing device or tub complete with spatula-device. Method of production of drugs: cap. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Side effects and complications in the use of drugs: nausea, vomiting, renew dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, Pulmonary Artery Pressure jaundice.